| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.36B | $3.27B | $3.09B |
| YoY Revenue Growth % | +3.0% | +5.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $496.3M | $399.1M | $335.1M |
| Operating Margin % | 14.8% | 12.2% | 10.8% |
| Net Income (GAAP) | $354.6M | $286.7M | $222.9M |
| EBITDA (Normalized) | $617.4M | $516.7M | $446.4M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $670.2M | $756.5M | $540.2M |
| Capital Expenditures (CapEx) | $151.4M | $147.0M | $139.1M |
| Free Cash Flow (FCF) | $518.8M | $609.5M | $401.1M |
| FCF Margin % | 15.4% | 18.7% | 13.0% |
| Return on Invested Capital (ROIC %) | 9.3% | 7.6% | 10.3% |
| Cash & Short-Term Equivalents | $78.8M | $74.4M | — |
| Total Debt (Short + Long Term) | $911.9M | $866.7M | $992.1M |
| Total Stockholders' Equity | $3.38B | $3.35B | $2.04B |